Patents Assigned to University
  • Patent number: 12254420
    Abstract: The disclosure discloses a point-of-interest recommendation method based on a temporal knowledge graph. Based on the historical behavior trajectory of the user and multimodal information, the disclosure constructs a dynamic temporal knowledge graph and a static group knowledge graph, which are used to learn interest preferences of the user that change over time and stable features that do not change over time, respectively. At the same time, the disclosure uses deep learning methods to build a point-of-interest recommendation model, which can extract a point-of-interest fusion feature representation and a user fusion feature representation from the two knowledge graphs in combination with a user review sentiment embedding sequence to accurately predict a point of interest most likely to be visited by the target user at a next moment. The disclosure has the characteristics of high precision and strong scalability, and can provide support for personalized user behavior trajectory prediction.
    Type: Grant
    Filed: November 12, 2024
    Date of Patent: March 18, 2025
    Assignees: Hangzhou Dianzi University Binjiang Institute Co., Ltd., Hangzhou Dianzi University
    Inventors: Xiao Xiao Sun, Dong Jin Yu, Bo Yi Huang, Si Xuan Wang, Dong Jing Wang, Yao Wang Chen
  • Patent number: 12251758
    Abstract: A method of additively manufacturing a structure for use in a reactionary process includes forming a material from metal or metal oxide particles, a dispersion solvent, and a binder. The method also includes depositing the material onto a build platform and curing the material to form a structure for use in a reactionary process. The structure includes the metal or metal oxide particles and is configured to provide a reaction when exposed to a reactant.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: March 18, 2025
    Assignee: The Curators of the University of Missouri
    Inventors: Fateme Rezaei, Ali Rownaghi, Shane Lawson
  • Patent number: 12251421
    Abstract: FSP27 compositions and methods for treating cancers are described.
    Type: Grant
    Filed: March 26, 2024
    Date of Patent: March 18, 2025
    Assignee: Ohio University
    Inventors: John J. Kopchick, Vishwajeet Puri, Vishva Sharma, Reetobrata Basu
  • Patent number: 12253418
    Abstract: A method for in situ measurement of temperature at microwave-induced microscopic hot spots, temperature measuring particles and the device used are provided. For the temperature measurement demand of the microscopic hot spot of microwave field, loading fluorescent temperature measuring particles on the surface of solid particles, and the actual temperature of particles in micro scale can be measured by using its temperature sensitive fluorescence characteristics. The present disclosure builds a microwave field in-situ fluorescence test device to disperse the test particles loaded with fluorescent temperature measuring materials in the liquid solvent and place in the quartz sample tank in the microwave cavity, which can measure the actual temperature of the particles to be measured under microwave radiation.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: March 18, 2025
    Assignee: Tianjin University
    Inventors: Xin Gao, Zhenyu Zhao, Hong Li
  • Patent number: 12252675
    Abstract: Tissue culture platforms that may be configured for tissue culture or biological cell culture, and methods for use thereof, are described. In general, the tissue culture platforms include multiple well chambers that are fluidically coupled by one or more channels Flow between the different well chambers is controlled via one or more selector valves, enabling a single tissue culture platform that can provide multiple integrated culture subsystems, multiple non-interacting culture subsystems, or combinations thereof.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: March 18, 2025
    Assignee: Northwestern University
    Inventors: Hunter B. Rogers, Teresa K. Woodruff, Ji-Yong Julie Kim, Hannes Marcus Campo
  • Patent number: 12253522
    Abstract: Provided herein is a method for treating a cancer in a subject by quantitating the concentration of a soluble form of Semaphorin 4D (sSema4D) in a blood sample obtained from the subject and administering an immunotherapy when the blood concentration of sSema4D is below a threshold value of 155 ng/ml. Also provided is a method for determining the continued susceptibility of a tumor tissue to immunotherapy in a subject by identifying the inflammatory subtype of the tumor tissue from a blood sample from the subject and administering immunotherapy over at least one interval as long as the tumor tissue exhibits an inflamed subtype.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: March 18, 2025
    Assignee: University of Maryland, Baltimore
    Inventor: Rania H. Younis
  • Patent number: 12251420
    Abstract: Compositions and methods for the promotion of wound healing and tissue regeneration are described. The compositions and methods make use of water-soluble soy protein isolates (WSsoy), Fraction 5, Fraction 9, and/or bioactive peptide components of soy protein isolates. The invention also relates to the unexpected discovery that purified WSsoy forms gel-like matrices when suspended within certain concentration ranges in an aqueous environment. The compositions of the invention comprising WSsoy promote natural healing and have a low risk profile.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: March 18, 2025
    Assignee: Temple University—Of The Commonwealth System of Higher Education
    Inventors: Peter I. Lelkes, Yah-el H. Har-el, Cezary Marcinkiewicz, Philip Lazarovici, Sogol Moaiyed Baharlou, Jonathan A. Gerstenhaber
  • Patent number: 12251392
    Abstract: The invention relates generally to a pharmacological therapy for human genetic diseases, specifically those characterized by unbalance nucleotide pools, more specifically mitochondrial DNA depletion syndromes, and more specifically, thymidine kinase 2 (TK2) deficiency. The pharmacological therapy involves the administration of at least one deoxynucleoside, or mixtures thereof. For the treatment of TK2 deficiency, the pharmacological therapy involves the administration of either deoxythymidine (dT) or deoxycytidine (dC), or mixtures thereof. This administration of deoxynucleosides is applicable to other disorders of unbalanced nucleotide pools, especially those found in mitochondrial DNA depletion syndrome.
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: March 18, 2025
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Michio Hirano, Caterina Garone, Ramon Marti
  • Patent number: 12251522
    Abstract: The present disclosure belongs to the technical field of medical devices, and in particular relates to a post-operative indwelling urinary catheter suitable for males. In view of a problem that a urinary catheter is prone to shaking due to collision, in the present disclosure, by arranging a shield, a limiting ring is rotated to adjust a connection position of a spiral tube and a chassis, and the shield is pushed to cause a fixing soft disk to be abutted against a human body, avoiding the possibility of urethral irritation or injury when an external urinary catheter I is shaken, avoiding bacterial invasion and urinary tract infection, and improving the comfort of use.
    Type: Grant
    Filed: November 6, 2024
    Date of Patent: March 18, 2025
    Assignee: Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University
    Inventors: Yanfei Chen, Guoshuo Chen, Ling Li, Yingwen Zhu, Xuejin Zhu, Sian Chen, Jinhai Wu
  • Patent number: 12252730
    Abstract: Methods of uniquely labeling or barcoding molecules within a nucleus, a plurality of nuclei, a cell, a plurality of cells, and/or a tissue are provided. Kits for uniquely labeling or barcoding molecules within a nucleus, a plurality of nuclei, a cell, a plurality of cells, and/or a tissue are also provided. The molecules to be labeled may include, but are not limited to, RNAs and/or cDNAs.
    Type: Grant
    Filed: April 21, 2023
    Date of Patent: March 18, 2025
    Assignee: University of Washington
    Inventors: Georg Seelig, Alexander B. Rosenberg, Charles Roco
  • Patent number: 12255452
    Abstract: A method for constructing a dynamic security region of a power grid based on an extended phase trajectory theory includes: obtaining a system transient stability condition and a power angle leading generator group by transient simulation of an initial operation point of a system; for generators in the leading generator group A, changing output of each of the generators to search for a dominant instability critical point; calculating the reciprocal of the slope of the tangent line of the trajectory of n swings of an extended phase plane based on angular velocity-angular acceleration in a fourth quadrant, and changing a small disturbance output of the generator at the dominant instability critical point to solve a sensitivity of the extended phase trajectory; and constructing a multi-modal practical dynamic security region based on the extended phase trajectory.
    Type: Grant
    Filed: August 23, 2024
    Date of Patent: March 18, 2025
    Assignee: Tianjin University
    Inventors: Yuan Zeng, Haosen Cao, Chao Qin, Yuzhuo Hu, Junzhi Ren
  • Patent number: 12254784
    Abstract: Disclosed are an emotional evolution method and terminal for a virtual avatar in educational metaverse.
    Type: Grant
    Filed: September 27, 2023
    Date of Patent: March 18, 2025
    Assignees: Fujian TQ Digital Inc, Central China Normal University
    Inventors: Dejian Liu, Yan Ge, Jing Peng, Zheng Zhong, Jian Xu
  • Patent number: 12254710
    Abstract: A method of predicting cancer recurrence risk for an individual includes receiving patient spatial multi-parameter cellular and sub-cellular imaging data for a tumor of the individual, and analyzing the patient spatial multi-parameter cellular and sub-cellular imaging data using a prognostic model for predicting cancer recurrence risk to determine a predicted cancer recurrence risk for the individual, wherein the joint prognostic model is based on spatial correlation statistics among features derived for a plurality of intra-tumor spatial domains from spatial multi-parameter cellular and sub-cellular imaging data obtained from a plurality of cancer patients.
    Type: Grant
    Filed: October 24, 2023
    Date of Patent: March 18, 2025
    Assignee: University of Pittsburgh—Of The Commonwealth System of Higher Education
    Inventors: Srinivas C. Chennubhotla, Douglass L. Taylor, Shikhar Uttam Fnu
  • Patent number: 12251404
    Abstract: Compositions and methods are provided for induction and maintenance of quiescence of stem cells.
    Type: Grant
    Filed: February 27, 2023
    Date of Patent: March 18, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Marco Quarta, Thomas A. Rando
  • Patent number: 12252774
    Abstract: Implementations of the disclosed subject matter provide a print bar for organic vapor jet (OVJP) deposition is provided that includes a plurality of n print head segments, where each of the plurality of print head segments may have an OVJP print head. The print bar may include a plurality of distance sensors, where each of the plurality of distance sensors may be configured to measure a distance between a substrate disposed below the print bar and a portion of at least one of the print head segments. The print bar may include a plurality of not more than n+1 actuators configured to adjust at least one of a position and an orientation of one or more of the plurality of print head segments based upon one or more distances between the substrate and the print bar measured by one or more of the plurality of distance sensors.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: March 18, 2025
    Assignee: Universal Display Corporation
    Inventors: William E. Quinn, Gregory McGraw
  • Patent number: 12251429
    Abstract: Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to one or more target nucleic acid sequences in a retrovirus genome.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: March 18, 2025
    Assignee: Temple University—of the Commonwealth System of Higher Education
    Inventors: Kamel Khalili, Wenhui Hu, Yonggang Zhang
  • Patent number: 12252697
    Abstract: The present invention refers to a plant or plant part comprising a polynucleotide encoding an herbicide tolerant IAA2 polypeptide having a deleted or disrupted degron tail region, the expression of said polynucleotide confers to the plant or plant part tolerance to synthetic auxin herbicides, such as 2,4-D. The present invention relates to methods and plants and that have a deleted or disrupted degron tail region of the IAA2 protein obtained by gene editing, transformation, mutagenesis, breeding, and the like.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: March 18, 2025
    Assignees: Colorado State University Research Foundation, University of Adelaide
    Inventors: Todd Gaines, Marcelo Rodrigues Alves De Figueiredo, Anita Küpper, Christopher Preston
  • Patent number: 12252733
    Abstract: Methods of uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are provided. Kits for uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are also provided. The molecules to be labeled may include, but are not limited to, RNAs, cDNAs, DNAs, proteins, peptides, and/or antigens.
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: March 18, 2025
    Assignee: University of Washington
    Inventors: Georg Seelig, Richard Muscat, Alexander B. Rosenberg
  • Patent number: 12253515
    Abstract: Provided are an expression inhibitor of a cancer promoting factor based on the discovery of a new factor influencing the expression amount/level of a cancer promoting factor, and a development tool therefor. Provided are also a diagnostic agent and a diagnosis method for cancer. More specifically provided are: an expression inhibitor of a cancer promoting factor containing at least one kind of inhibitor selected from the group consisting of RBMS expression inhibitor and RBMS function inhibitor; a screening method using as an indicator the expression or the function of RBMS; an expression cassette useful for the method; as well as a diagnostic agent containing a product detection agent for RBMS gene expression and cancer detection method using as an indicator RBMS gene expression amount/level.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: March 18, 2025
    Assignees: National University Corporation Tokyo Medical and Dental University, Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Hiroshi Asahara, Tomoki Chiba, Kentaro Abe
  • Patent number: 12254624
    Abstract: The subject invention pertains to methods and systems for classifying leukocytes using artificial intelligence called AIRFIHA (artificial-intelligence enabled reagent-free imaging hematology analyzer) that can accurately classify subpopulations of leukocytes in a label-free manner. AIRFIHA can not only subtype lymphocytes into B and T cell but is capable of sorting different types of T cells subtypes. AIRFIHA is realized through training a two-step neural network using label-free images of separated leukocytes acquired from a custom-built quantitative phase microscope. Owing to its easy operation, low cost, and strong discerning capability of complex leukocyte subpopulations, AIRFIHA is clinically translatable and can also be deployed in resource-limited settings.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: March 18, 2025
    Assignee: The Chinese University of Hong Kong
    Inventors: Renjie Zhou, Xin Shu, Rishikesh Pandey